Clinical Trial Update: A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum [Phase 2]

View source ↗

Summary

Phase 2 trial update for VBP-245 in pediatric Molluscum Contagiosum has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Molluscum Contagiosum

Drugs mentioned

• VBP-245

Snippet

Sponsor: Veloce BioPharma LLC | Conditions: Molluscum Contagiosum | Phase 2 | Status: COMPLETED